Lydia Min-Ying Su

picture of Lydia Min-Ying  Su

Tu & Yuen Center for Functional Onco-Imaging, Radiological Sciences
School of Medicine

M.S., University of California, Irvine, California
Ph.D., University of California, Irvine, California, Physics

Phone: (949) 824-4925

University of California, Irvine
CFOI, 164 Irvine Hall
University of California
Mail Code: 5020
Irvine, CA 92697
Available Technologies
Last Ten Years of Publications

J-144 Zhou J, Chen E, Xu H, Ye Q, Li J, Ye S, Cheng Q, Zhao L, Su MY, Wang M. Feasibility and Diagnostic Performance of Voxelwised Computed Diffusion Weighted Imaging in Breast Cancer. J Magn Reson Imaging. 2018 Oct 16. doi: 10.1002/jmri.26533. [Epub ahead of print]

J-143 Chang PD, Kuoy E, Grinband J, Weinberg BD, Thompson M, Homo R, Chen J, Abcede H, Shafie M, Sugrue L, Filippi CG, Su MY, Yu W, Hess C, Chow D. Hybrid 3D/2D Convolutional Neural Network for Hemorrhage Evaluation on Head CT. AJNR Am J Neuroradiol. 2018 Sep;39(9):1609-1616. doi: 10.3174/ajnr.A5742. Epub 2018 Jul 26.

J-142 Chen JH, Zhang Y, Chan S, Chang RF, Su MY. Quantitative analysis of peri-tumor fat in different molecular subtypes of breast cancer. Magn Reson Imaging. 2018 Jun 30;53:34-39. doi: 10.1016/j.mri.2018.06.019.

J-141 Shin GW, Zhang Y, Kim MJ, Su MY, Kim EK, Moon HJ, Yoon JH, Park VY. Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer. J Magn Reson Imaging. 2018 Dec;48(6):1678-1689. doi: 10.1002/jmri.26176. Epub 2018 May 7.

J-140 Chang P, Grinband J, Weinberg BD, Bardis M, Khy M, Cadena G, Su MY, Cha S, Filippi CG, Bota D, Baldi P, Poisson LM, Jain R, Chow D. Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas. AJNR Am J Neuroradiol. 2018 Jul;39(7):1201-1207. doi: 10.3174/ajnr.A5667. Epub 2018 May 10.

J-139 Ruiz J, Nouizi F, Cho J, Zheng J, Li Y, Chen JH, Su MY, Gulsen G. Breast density quantification using structured-light-based diffuse optical tomography simulations. Appl Opt. 2017 Sep 1;56(25):7146-7157. doi: 10.1364/AO.56.007146.

J-138 Skarecky D, Yu H, Linehan J, Morales B, Su MY, Fwu P, Ahlering T. Hypothermic Cooling Measured by Thermal Magnetic Resonance Imaging; Feasibility and Implications for Virtual Imaging in the Urogenital Pelvis. Urology. 2017 Jul 18. pii: S0090-4295(17)30731-8. doi: 10.1016/j.urology.2017.07.006. [Epub ahead of print]

J-137 McLaren CE, Chen WP, O'Sullivan TD, Gillen DL, Su MY, Chen JH, Tromberg BJ. Sample size and power determination when limited preliminary information is available. BMC Med Res Methodol. 2017 Apr 26;17(1):75. doi: 10.1186/s12874-017-0329-1. (PMCID: 5406943)

J-136 Chan S, Chen JH, Li S, Chang R, Yeh DC, Chang RF, Yeh LR, Kwong J, Su MY. Evaluation of the association between quantitative mammographic density and breast cancer occurred in different quadrants. BMC Cancer. 2017 Apr 17;17(1):274. doi: 10.1186/s12885-017-3270-0. (PMCID: 5392962)

J-135 Yin XX, Hadjiloucas S, Chen JH, Zhang Y, Wu JL, Su MY. Tensor based multichannel reconstruction for breast tumours identification from DCE-MRIs. PLoS One. 2017 Mar 10;12(3):e0172111. doi: 10.1371/journal.pone.0172111. eCollection 2017. Erratum in: PLoS One. 2017 Apr 13;12 (4):e0176133.

J-134 Wang J, Fang Z, Lang N, Yuan H, Su MY, Baldi P. A multi-resolution approach for spinal metastasis detection using deep Siamese neural networks. Comput Biol Med. 2017 May 1;84:137-146. doi: 10.1016/j.compbiomed.2017.03.024. Epub 2017 Mar 27.

J-133 Choi YJ, Chen JH, Yu HJ, Li Y, Su MY. Impact of Different Analytic Approaches on the Analysis of the Breast Fibroglandular Tissue Using Diffusion Weighted Imaging. Biomed Res Int. 2017;2017:1094354. doi: 10.1155/2017/1094354. Epub 2017 Mar 2. (PMCID: 5352872)

J-132 Lang N, Yuan H, Yu HJ, Su MY. Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI. Acad Radiol. 2017 Jul;24(7):867-875. doi: 10.1016/j.acra.2016.12.014. Epub 2017 Feb 2.

J-131 Chen JH, Liao F, Zhang Y, Li Y, Chang CJ, Chou CP, Yang TL, Su MY. 3D MRI for Quantitative Analysis of Quadrant Percent Breast Density: Correlation with Quadrant Location of Breast Cancer. Acad Radiol. 2017 Jul;24(7):811-817. doi: 10.1016/j.acra.2016.12.016. Epub 2017 Jan 26. (PMCID: 5482764)

J-130 Lang N, Su MY, Xing X, Yu HJ, Yuan H. Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton. J Magn Reson Imaging. 2017 Apr;45(4):1068-1075. doi: 10.1002/jmri.25414. Epub 2016 Aug 4.

J-129 Nolen SC, Lee B, Shantharam S, Yu HJ, Su L, Billimek J, Bota DA. The effects of sequential treatments on hippocampal volumes in malignant glioma patients. J Neurooncol. 2016 Sep;129(3):433-441. doi: 10.1007/s11060-016-2188-8. Epub 2016 Jul 8. (PMCID: 5097045)

J-128 Kwong TC, Hsing M, Lin Y, Thayer D, Unlu MB, Su MY, Gulsen G. Differentiation of tumor vasculature heterogeneity levels in small animals based on total hemoglobin concentration using magnetic resonance-guided diffuse optical tomography in vivo. Appl Opt. 2016 Jul 20;55(21):5479-87.

J-127 Chen JH, Chan S, Lu NH, Li Y, Tsai YC, Huang PY, Chang CJ, Su MY. Opportunistic Breast Density Assessment in Women Receiving Low-dose Chest Computed Tomography Screening. Acad Radiol. 2016 Sep;23(9):1154-61. doi: 10.1016/j.acra.2016.05.003. Epub 2016 Jun 6. (PMCID: 4987249)

J-126 Kim MJ, Su MY, Yu HJ, Chen JH, Kim EK, Moon HJ, Choi JS. US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers. BMC Cancer. 2016 Feb 1;16:50. doi: 10.1186/s12885-016-2086-7. (PMCID: 4736271)

J-125 Yin XX, Hadjiloucas S, Zhang Y, Su MY, Miao Y, Abbott D. Pattern identification of biomedical images with time series: Contrasting THz pulse imaging with DCE-MRIs. Artif Intell Med. 2016 Feb;67:1-23. doi: 10.1016/j.artmed.2016.01.005. Epub 2016 Feb 16.

J-124 Chen JH, Gulsen G, Su MY. Imaging Breast Density: Established and Emerging Modalities. Transl Oncol. 2015 Dec;8(6):435-45. doi: 10.1016/j.tranon.2015.10.002. (PMCID: 4700291)

J-123 Wu AH, Spicer D, Garcia A, Tseng CC, Hovanessian-Larsen L, Sheth P, Martin SE, Hawes D, Russell C, MacDonald H, Tripathy D, Su MY, Ursin G, Pike MC. Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density. Cancer Prev Res (Phila). 2015 Oct;8(10):942-51. doi: 10.1158/1940-6207.CAPR-15-0125. Epub 2015 Aug 14. (PMCID: 4596769)

J-122 Zhen Wang, Gang Zhao, Tao Wang, Qianfeng Yu, Minying Su, Xiaoming He. Three-dimensional Numerical Simulation of the Effects of Fractal Vascular Trees on Tissue Temperature and Intracelluar Ice Formation during Combined Cancer Therapy of Cryosurgery and Hyperthermia. Applied Thermal Engineering, 2015 Nov;90(5):296-304.

J-121 Lin Y, Lin WC, Fwu PT, Shih TC, Yeh LR, Su MY, Chen JH. Investigation of factors affecting hypothermic pelvic tissue cooling using bio-heat simulation based on MRI-segmented anatomic models. Comput Methods Programs Biomed. 2015 Oct;122(1):76-88. doi: 10.1016/j.cmpb.2015.07.002. Epub 2015 Jul 13. (PMCID: 4549219)

J-120 Fwu PT, Chen JH, Li Y, Chan S, Su MY. Quantification of Regional Breast Density in Four Quadrants Using 3D MRI-A Pilot Study. Transl Oncol. 2015 Aug;8(4):250-257. doi: 10.1016/j.tranon.2015.04.005. (PMCID: 4562976)

J-119 Chen JH, Yu HJ, Hsu C, Mehta RS, Carpenter PM, Su MY. Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Transl Oncol. 2015 Jun;8(3):204-9. doi: 10.1016/j.tranon.2015.04.001. (PMCID: 4487259)

J-118 Chen JH, Chan S, Tang YT, Hon JS, Tseng PC, Cheriyan AT, Shah NR, Yeh DC, Lee SK, Chen WP, McLaren CE, Su MY. Impact of Positional Difference on the Measurement of Breast Density Using MRI. Med Phys. 2015 May;42(5):2268. doi: 10.1118/1.4917083. (PMCID: 4401799)

J-117 Lang N, Su MY, Yu HJ, Yuan H. Differentiation of tuberculosis and metastatic cancer in the spine using dynamic contrast-enhanced MRI. Eur Spine J. 2015 Aug;24(8):1729-37. doi: 10.1007/s00586-015-3851-z. Epub 2015 Mar 8.

J-116 Bahri S, Kain TS, Mehta RS, Herman J, Kuzucan A, Chen JH, Kolb HC, Walsh JC, Su MY. Initial Experience of Monitoring Response of Breast Cancer to Bevacizumab-containing Chemotherapy using A New Integrin Specific PET Imaging Tracer [F-18]RGD-K5. J. Molecular Imaging & Dynamics 2015, 5:1.

J-115 Bonev V, Evangelista M, Chen JH, Su MY, Lane K, Mehta R, Butler J, Hsiang D. Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy. Am Surg. 2014 Oct;80(10):940-3. (PMCID: 4343309)

J-114 Sandman CA, Head K, Muftuler LT, Su L, Buss C, Davis EP. Shape of the basal ganglia in preadolescent children is associated with cognitive performance. Neuroimage. 2014 Oct 1;99:93-102. doi: 10.1016/j.neuroimage.2014.05.020. Epub 2014 May 17. (PMCID: 4112008)

J-113 Chen JH, Bahri S, Mehta RS, Carpenter PM, McLaren CE, Chen W-P, Fwu PT, Hsiang DJ, Lane KT, Butler JA, Su MY. Impact of Factors Affecting the Residual Tumor Size Diagnosed by Following Neoadjuvant Chemotherapy in Comparison to Pathology. J Surg Oncol. 2014 Feb;109(2):158-67. doi: 10.1002/jso.23470. Epub 2013 Oct 28. (PMCID: 4005994)

J-112 Ding H, Johnson T, Lin M, Le HQ, Ducote JL, Su MY, Molloi S. Breast density quantification using magnetic resonance imaging (MRI) with bias field correction: A postmortem study. Med Phys. 2013 Dec;40(12):122305. doi: 10.1118/1.4831967. (PMCID: 3862600)

J-111 Lin M, Chen JH, Wang X, Chan S, Chen S, Su MY. Template-based automatic breast segmentation on MRI by excluding the chest region. Med Phys. 2013 Dec;40(12):122301. doi: 10.1118/1.4828837. (PMCID: 3843758)

J-110 Chien DT, Szardenings AK, Bahri S, Walsh JC, Mu F, Xia C, Shankle WR, Lerner AJ, Su MY, Elizarov A, Kolb HC. Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808. J Alzheimers Dis. 2014 Jan 1;38(1):171-84. doi: 10.3233/JAD-130098. E-pub: Aug 12.

J-109 Chen JH, Yu H, Lin M, Mehta RS, Su MY. Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI. Magn Reson Imaging. 2013 Nov;31(9):1465-71. doi: 10.1016/j.mri.2013.07.014. Epub 2013 Aug 29. (PMCID: 3795886)

J-108 Chen JH, Pan WF, Kao J, Lu J, Chen LK, Kuo CC, Chang CK, Chen WP, McLaren CE, Bahri S, Mehta RS, Su MY. Effect of taxane-based neoadjuvant chemotherapy on fibroglandular tissue volume and percent breast density in the contralateral normal breast evaluated by 3T MR. NMR Biomed. 2013 Dec;26(12):1705-13. doi: 10.1002/nbm.3006. Epub 2013 Aug 12. (PMCID: 3838444)

J-107 Lin M, Fwu PT, Buss C, Davis EP, Head K, Muftuler LT, Sandman CA, Su MY. Developmental changes in hippocampal shape among preadolescent children. Int J Dev Neurosci. 2013 Jun 14;31(7):473-481. doi: 10.1016/j.ijdevneu.2013.06.001. (PMCID: 3836360)

J-106 Chen JH, Su MY. Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy. Biomed Res Int. 2013;2013:348167. doi: 10.1155/2013/348167. (PMCID: 3687601)

J-105 Chen JH, Chen WP, Chan S, Yeh DC, Su MY, McLaren CE. Correlation of endogenous hormonal levels, fibroglandular tissue volume and percent density measured using 3D MRI during one menstrual cycle. Ann Oncol. 2013 Sep;24(9):2329-35. doi: 10.1093/annonc/mdt158. (PMCID: 3755325)

J-104 O'Sullivan TD, Leproux A, Chen JH, Bahri S, Matlock A, Roblyer D, McLaren CE, Chen WP, Cerussi AE, Su MY, Tromberg BJ. Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy. Breast Cancer Res. 2013 Feb 22;15(1):R14. (PMCID: 3672664)

J-103 Chien DT, Bahri S, Szardenings AK, Walsh JC, Mu F, Su MY, Shankle WR, Elizarov A, Kolb HC. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis. 2013 Jan 1;34(2):457-68. doi: 10.3233/JAD-122059.

J-102 Chen JH, Chan S, Yeh DC, Fwu PT, Lin M, Su MY. Response of bilateral breasts to the endogenous hormonal fluctuation in a menstrual cycle evaluated using 3D MRI. Magn Reson Imaging. 2013 May;31(4):538-44. doi: 10.1016/j.mri.2012.10.022. Epub 2012 Dec 5. (PMCID: 3597749)

J-101 Lang N, Su MY, Yu HJ, Lin M, Hamamura MJ, Yuan H. Differentiation of myeloma and metastatic cancer in the spine using dynamic contrast-enhanced MRI. Magn Reson Imaging. 2013 Oct;31(8):1285-91. doi: 10.1016/j.mri.2012.10.006. Epub 2013 Jan 3. (PMCID: 3620894)

J-100 Ho CY, Liao HM, Tu CY, Huang CY, Shih CM, Su MY, Chen JH, Shih TC. Numerical analysis of airflow alteration in central airways following tracheobronchial stent placement. Exp Hematol Oncol. 2012 Aug 27;1(1):23. doi: 10.1186/2162-3619-1-23. (PMCID: 3514122)

J-99. Chen JH, Chan S, Liu YJ, Yeh DC, Chang CK, Chen LK, Pan WF, Kuo CC, Lin M, Chang DH, Fwu PT, Su MY. Consistency of breast density measured from the same women in four different MR scanners. Med Phys. 2012 Aug;39(8):4886-95. doi: 10.1118/1.4736824. (PMCID: 3411588)

J-98. Muftuler LT, Davis EP, Buss C, Solodkin A, Su MY, Head KM, Hasso AN, Sandman CA. Development of white matter pathways in typically developing preadolescent children. Brain Res. 2012 Jul 23;1466:33-43. doi: 10.1016/j.brainres.2012.05.035. (PMCID: 3389170)

J-97. Keyvanfard F, Shoorehdeli MA, Teshnehlab M, Nie K, Su MY. Specificity enhancement in classification of breast MRI lesion based on multi-classifier. Neural Computing and Applications. 2013 May, 22(1):35-45. DOI 10.1007/s00521-012-0937-y

J-96. Su MY, Chen JH. Analysis of DCE-MRI for diagnosis and neoadjuvant chemotherapy monitoring of breast cancer. Chin J Magn Reson Imaging, 2012, 3(2):235-248. (PMCID: 3687601)

J-95. Kuzucan A, Chen JH, Bahri S, Mehta RS, Carpenter PM, Fwu PT, Yu HJ, Hsiang DJ, Lane KT, Butler JA, Feig SA, Su MY. Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile. Clin Breast Cancer. 2012 Apr;12(2):110-8. (PMCID: 3342312)

J-94. Chung SH, Yu HJ, Su MY, Cerussi AE, Tromberg BJ. Molecular imaging of water binding state and diffusion in breast cancer using diffuse optical spectroscopy and diffusion weighted MRI. J. Biomed. Opt. 17, 071304 (2012), DOI:10.1117/1.JBO.17.7.071304 (PMCID: 3381027)

J-93. Chen JH, Chan S, Chang DH, Lin M, Su MY. Consistency of breast density measured from the same women using different MR scanners. Ann Oncol. 2011 Dec;22(12):2693-4. Epub 2011 Oct 19. (PMCID: 3221515).

J-92. Chang DH, Chen JH, Lin M, Bahri S, Yu HJ, Mehta RS, Nie K, Hsiang DJ, Nalcioglu O, Su MY. Comparison of breast density measured on MR images acquired using fat-suppressed versus nonfat-suppressed sequences. Med Phys. 2011 Nov;38(11):5961-8. (PMCID: 3215688)

J-91. Lin M, Chen JH, Mehta RS, Bahri S, Chan S, Nalcioglu O, Su MY. Spatial shrinkage/expansion patterns between breast density measured in two MRI scans evaluated by non-rigid registration. Phys Med Biol. 2011 Sep 21;56(18):5865-75. Epub 2011 Aug 18. (PMCID: 3498815)

J-90. Chen JH, Bahri S, Mehta RS, Kuzucan A, Yu HJ, Carpenter PM, Feig SA, Lin M, Hsiang DJ, Lane KT, Butler JA, Nalcioglu O, Su MY. Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR Imaging. Radiology. 2011 Dec;261(3):735-43. Epub 2011 Aug 30. (PMCID: 3219909)

J-89. Chan S, Su MY, Lei FJ, Wu JP, Lin M, Nalcioglu O, Feig SA, Chen JH. Menstrual Cycle-related Fluctuations in Breast Density Measured by Using Three-dimensional MR Imaging. Radiology. 2011 Dec;261(3):744-51. Epub 2011 Aug 30. (PMCID: 3219914)

J-88. Sharma U, Baek HM, Su MY, Jagannathan NR. In vivo (1) H MRS in the assessment of the therapeutic response of breast cancer patients. NMR Biomed. 2011 Jul;24(6):700-11. Epub 2011 Jan 28.

J-87. Lin M, Chan S, Chen JH, Chang D, Nie K, Chen ST, Lin CJ, Shih TC, Nalcioglu O, Su MY. A new bias field correction method combining N3 and FCM for improved segmentation of breast density on MRI. Med Phys. 2011 Jan;38(1):5-14. (PMCID: 3017578)

J-86. Chan S, Chen JH, Agrawal G, Lin M, Mehta RS, Carpenter PM, Nalcioglu O, Su MY. Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features? J Oncol. 2010;2010. pii: 431341. Epub 2010 Sep 21. (PMCID: 2946595)

J-85. Chen JH, Mehta RS, Baek HM, Nie K, Liu H, Lin MQ, Yu HJ, Nalcioglu O, Su MY. Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS. NMR Biomed. 2011 Apr;24(3):316-24. Epub 2010 Sep 22. (PMCID: 3075960)

J-84. Chen JH, Chang YC, Chang D, Wang YT, Nie K, Chang RF, Nalcioglu O, Huang CS, Su MY. Reduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary study. Magn Reson Imaging. 2011 Jan;29(1):91-8. Epub 2010 Sep 15. (PMCID: 3005955)

J-83. Shih TC, Chen JH, Liu D, Nie K, Sun L, Lin M, Chang D, Nalcioglu O, Su MY. Computational simulation of breast compression based on segmented breast and fibroglandular tissues on magnetic resonance images. Phys Med Biol. 2010 Jul 21;55(14):4153-68. Epub 2010 Jul 5. (PMCID: 2993491)

J-82. Nie K, Su MY, Chau MK, Chan S, Nguyen H, Tseng T, Huang Y, McLaren CE, Nalcioglu O, Chen JH. Age- and race-dependence of the fibroglandular breast density analyzed on 3D MRI. Med Phys. 2010 Jun;37(6):2770-6. (PMCID: 2885945)

J-81. Chen JH, Mehta RS, Nalcioglu O, Su MY. Magnetic Resonance Imaging Evaluation of Noninflammatory Breast Cancer with Skin Involvement After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2010 Jul;17(7):1964-5. Epub 2010 Feb 24 (PMCID: 2889290)

J-80. Liao J, Zhu Y, Zhang M, Yuan H, Su MY, Yu X, Wang H. Microstructural white matter abnormalities independent of white matter lesion burden in amnestic mild cognitive impairment and early Alzheimer disease among Han Chinese elderly. Alzheimer Dis Assoc Disord. 2010 Aug;24:317–324.

J-79. Nalcioglu O, Su MY. Foreword (A Special Issue for Multimodal-Imaging). Technol Cancer Res Treat. 2010 Feb;9(1):1-4.

J-78. Mehta RS, Su MY. Continued Exploration of Bevacizumab in Breast Cancer. Ann Surg Oncol 2010 Feb;17(2): 655-656. (PMCID: 2816792)

J-77. Nie K, Chang D, Chen JH, Shih TC, Hsu CC, Nalcioglu O, Su MY. Impact of skin removal on quantitative measurement of breast density using MRI. Med Phys. 2010 Jan;37(1):227-33. (PMCID: 2801738)

J-76. Nie K, Chang D, Chen JH, Hsu CC, Nalcioglu O, Su MY. Quantitative analysis of breast parenchymal patterns using 3D fibroglandular tissues segmented based on MRI. Med Phys. 2010 Jan;37(1):217-26. (PMCID: 2801737)

J-75. Baek HM, Chen JH, Nalcioglu O, Su MY. Can proton MRS provide useful information for characterizing estrogen receptor status in breast cancer? Ann Oncol. 2010 Mar;21(3):663-5. Epub 2009 Nov 30. (PMCID: 2826101)

J-74. Chen JH, Nie K, Bahri S, Hsu CC, Hsu FT, Shih HN, Lin M, Nalcioglu O, Su MY. Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation. Radiology. 2010 Apr;255(1):44-52. (PMCID: 2843830)

J-73. Newell D, Nie K, Chen JH, Hsu CC, Yu HJ, Nalcioglu O, Su MY. Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement. Eur Radiol. 2010 Apr;20(4):771-81. Epub 2009 Sep 30. (PMCID: 2835636)

J-72. Lin M, Chen JH, Nie K, Chang D, Nalcioglu O, Su MY. Algorithm-based method for detection of blood vessels in breast MRI for development of computer-aided diagnosis. J Magn Reson Imaging. 2009 Oct;30(4):817-24. (PMCID: 2789993)

J-71. Chen JH, Chang D, Nie K, Hsu FT, Shih HN, Hsu CC, Nalcioglu O, Su MY. Comparison of breast density in the contralateral normal breast of patients with invasive and in situ breast cancer measured on MRI. Ann Oncol. 2009 Aug;20(8):1449-50. (PMCID: 2733064)

J-70. Chen JH, Hsu FT, Shih HN, Hsu CC, Chang D, Nie K, Nalcioglu O, Su MY. Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI? Ann Oncol. 2009 Aug;20(8):1447-9. (PMCID: 2720819)

J-69. Bahri S, Chen JH, Mehta RS, Carpenter PM, Nie K, Kwon SY, Yu HJ, Nalcioglu O, Su MY. Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab. Ann Surg Oncol. 2009 Jun;16(6):1619-28. Epub 2009 Mar 31. (PMCID: 2786305)

J-68. Carpenter PM, Chen WP, Mendez A, McLaren CE, Su MY. Angiogenesis in the progression of breast ductal proliferations. Int J Surg Pathol. 2011 Jun;19(3):335-41. Epub 2009 Apr 29.

J-67. McLaren CE, Chen WP, Nie K, Su MY. Prediction of malignant breast lesions from MRI features: a comparison of artificial neural network and logistic regression techniques. Acad Radiol. 2009 Jul;16(7):842-51. Epub 2009 May 5. (PMCID: 2832583)

J-66. Baek HM, Chen JH, Nie K, Yu HJ, Bahri S, Mehta RS, Nalcioglu O, Su MY. Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology. 2009 Jun;251(3):653-62. Epub 2009 Mar 10. (PMCID: 2687529)

J-65. Chen JH, Feig BA, Hsiang DJ, Butler JA, Mehta RS, Bahri S, Nalcioglu O, Su MY. Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer. Ann Surg. 2009 Mar;249(3):448-54. (PMCID: 2789298)

J-64. Agrawal G, Su MY, Nalcioglu O, Feig SA, Chen JH. Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer. 2009 Apr 1;115(7):1363-80. (PMCID: 2748779)

J-63. Nie K, Chen JH, Chan S, Chau MK, Yu HJ, Bahri S, Tseng T, Nalcioglu O, Su MY. Development of a quantitative method for analysis of breast density based on three-dimensional breast MRI. Med Phys. 2008 Dec;35(12):5253-62. (PMCID: 2673600)

J-62. Chen JH, Mehta RS, Nalcioglu O, Su MY. Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response? Ann Surg Oncol. 2008 Dec;15(12):3609-13. Epub 2008 Sep 19. (PMCID: 2613188)

J-61. Nie K, Chen JH, Yu HJ, Chu Y, Nalcioglu O, Su MY. Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI. Acad Radiol. 2008 Dec;15(12):1513-25. (PMCID: 2791407)

J-60. Chen JH, Nalcioglu O, Su MY. Fibrocystic change of the breast presenting as a focal lesion mimicking breast cancer in MR imaging. J Magn Reson Imaging. 2008 Dec;28(6):1499-505. (PMCID: 2597344)

J-59. Wang H, Golob E, Bert A, Nie K, Chu Y, Dick MB, Mandelkern M, Su MY. Alterations in Regional Brain Volume and Individual MRI-Guided Perfusion in Normal Control, Stable Mild Cognitive Impairment, and MCI-AD Converter. J. Geriatric Psychology and Neurology 2009 Mar;22(1):35-45.

J-58. Chen JH, Nalcioglu O, Su MY. MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter? Ann Oncol. 2008 May;19(5):1024-6. Epub 2008 Mar 28. (PMCID: 2613432)

J-57. Chen JH, Liu H, Baek HM, Nalcioglu O, Su MY. Magnetic resonance imaging features of fibrocystic change of the breast. Magn Reson Imaging. 2008 Nov;26(9):1207-14. Epub 2008 Apr 23. (PMCID: 2613187)

J-56. Baek HM, Chen JH, Nalcioglu O, Su MY. Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy. Ann Oncol. 2008 May;19(5):1022-4. Epub 2008 Mar 27. (PMCID: 2613189)

J-55. Bahri S, Chen JH, Yu HJ, Kuzucan A, Nalcioglu O, Su MY. Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer? Ann Oncol. 2008 Apr;19(4):822-4. Epub 2008 Mar 5. (PMCID: 2613186)

J-54. Baek HM, Chen JH, Nalcioglu O, Su MY. Choline as a biomarker for cell proliferation: do the results from proton MR spectroscopy show difference between HER2/neu positive and negative breast cancers? Int J Cancer. 2008 Sep 1;123(5):1219-21. (PMCID: 2613431)

J-53. Chen JH, Baek HM, Nalcioglu O, Su MY. Estrogen receptor and breast MR imaging features: a correlation study. J Magn Reson Imaging. 2008 Apr;27(4):825-33. (PMCID: 2613434)

J-52. Baek HM, Chen JH, Yu HJ, Mehta R, Nalcioglu O, Su MY. Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging. 2008 May;27(5):1114-21. (PMCID: 2613433)

J-51. Baek HM, Yu HJ, Chen JH, Nalcioglu O, Su MY. Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer. Magn Reson Imaging. 2008 May;26(4):523-31. Epub 2007 Dec 3. (PMCID: 2653063)
1R21 CA208938 (PI: Su, M-Y) 08/01/2017 – 7/31/2019 NIH/NCI $424,875 Mammographic Density and Metabolic Genotyping for Predicting Cancer Prognosis 2R44 CA144079 (PI: Weinberg I; Subcontract PI: Su, M-Y) 06/01/2013 – 5/31/2018 NIH/NCI $1,912,183 (UCI budget: $508,875) Low-Dose MRI-Compatible Molecular Breast Imaging Device 2R01 CA127927 (PI: Su, M-Y) 04/01/2013 – 3/31/2018 NIH/NCI $3,474,466 Predicting Neoadjuvant Chemo Response/Prognosis Using Imaging Biomarkers 2R01 NS020989 25A1 (PI: Fisher, Mark) 9/01/2012 – 4/30/2018 NIH/NINDS $2,725,800 Hemorheological Factors in Cerebral Ischemia Role: Co-investigator P30 CA62203 (PI: Van Etten, Rick) 3/2009-2/2020 NIH/NCI Onco Imaging and Biotechnology Program University of California, Irvine Cancer Center Support Grant Role: OIB program clinical theme leader, GYN DOT co-director
Last updated